Comment on validation of diagnostic criteria for variant Creutzfeldt-Jakob disease

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 212-

  Lukic, Ana ^a,b   Mead, Simon ^a,b   Rudge, Peter ^a,b   Collinge, John ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOSAN POLYSULFATE;

BIOPSY TECHNIQUE; CLINICAL PRACTICE; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; HUMAN; LETTER; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VARIANT CREUTZFELDT JAKOB DISEASE;

BLOOD CHEMICAL ANALYSIS; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC VARIATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PALATINE TONSIL; PRIONS;

EID: 79551473753     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22273     Document Type: Letter

References (5)

1. Heath CA, Cooper SA, Murray K, etal. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 2010; 67: 761-770.
2. Ironside JW, Hilton DA, Ghani A, etal. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 355: 1693-1694.
3. Brandel JP, Heath CA, Head MW, etal. Variant CJD in France and the United Kingdom: evidence for the same agent strain. Ann Neurol 2009; 65: 249-256.
4. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-2668.
5. Kaski D, Mead S, Hyare H, etal. Variant CJD in a PRNP codon 129 heterozygous individual. Lancet 2009; 374: 2128.